Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
With topical treatment of skin diseases, the requirement of a high and reproducible drug uptake often still is not met. Moreover, drug targeting to specific skin strata may improve the use of agents which are prone to cause local unwanted effects. Recent investigations have indicated that improved uptake and skin targeting may become feasible by means of nanoparticular systems such as solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsions (NE). Here we describe techniques to characterize drug loading to carrier systems and skin penetration profiles by using the lipophilic dye nile red as a model agent. Since the mode of drug association with the particle matrix may strongly influence the efficiency of skin targeting, parelectric spectroscopy (PS) was used to differentiate between matrix incorporation and attachment to the particle surface and fluorescence spectroscopy (FS) to solve dye distribution within NLC particles. Nile red was incorporated into the lipid matrix or the covering tensed shell, respectively, of SLN and NLC with all the lipids studied (Compritol, Precirol, oleic acid, Miglyol). In NLC, the dye was enriched in the liquid phase. Next, nile red concentrations were followed by image analysis of vertical sections of pigskin treated with dye-loaded nanoparticular dispersions and an oil-in-water cream for 4 and 8 h in vitro. Following the SLN dispersions, dye penetration increased about fourfold over the uptake obtained following the cream. NLC turned out less potent (<threefold increase) and penetration appeared even reduced when applying a NE. In contrast to previous studies with glucocorticoids attached to the surface of SLN, a targeting effect was not detected here. Therefore, drug targeting appears to be more strictly related to the mode of interaction of drug and particle than penetration enhancement.
Lombardi Borgia
S
S
Institut für Pharmazie, Freie Universität Berlin, Germany.
Regehly
M
M
Sivaramakrishnan
R
R
Mehnert
W
W
Korting
H C
HC
Danker
K
K
Röder
B
B
Kramer
K D
KD
Schäfer-Korting
M
M
D000287:Administration, Topical; D000818:Animals; D003460:Crystallization; D004075:Diglycerides / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry*; D004655:Emulsions; D005227:Fatty Acids / Q000737:chemistry; D005456:Fluorescent Dyes / Q000737:chemistry* / Q000378:metabolism; D066298:In Vitro Techniques; D008055:Lipids / Q000737:chemistry*; D053758:Nanoparticles; D009821:Oils / Q000737:chemistry*; D019301:Oleic Acid / Q000737:chemistry; D010078:Oxazines / Q000737:chemistry* / Q000378:metabolism; D010316:Particle Size; D012867:Skin / Q000737:chemistry* / Q000378:metabolism; D012869:Skin Absorption; D013050:Spectrometry, Fluorescence / Q000379:methods*; D013499:Surface Properties; D013552:Swine; D014867:Water / Q000737:chemistry
D004075:Diglycerides; D004337:Drug Carriers; D004655:Emulsions; D005227:Fatty Acids; D005456:Fluorescent Dyes; D008055:Lipids; D009821:Oils; D010078:Oxazines; D014867:Water; C086409:glyceryl behenate; D019301:Oleic Acid; C009032:precirol; C044808:nile red